Serum Lipids, Lipoproteins, and Lipid Metabolizing Enzymes in Identical Twins Discordant for Obesity
Tapani Rönnemaa,
Jukka Marniemi,
Markku J. Savolainen,
Y. Antero Kesäniemi,
Christian Ehnholm,
Claude Bouchard and
Markku Koskenvuo
Departments of Medicine (T.R.) and Public Health (M.K.), University
of Turku, FIN-20520 Turku, Finland; Research and Development Center
(J.M.), Social Insurance Institution, FIN-20720 Turku, Finland;
Department of Internal Medicine and Biocenter Oulu (M.J.S., Y.A.K.),
University of Oulu, FIN-90220 Oulu, Finland; Physical Activity Sciences
Laboratory (C.B.), Laval University, Quebec G1K 7P4, Canada; and Public
Health Institute (C.E.), FIN-00300 Helsinki, Finland
Address all correspondence and requests for reprints to: T. Rönnemaa, Department of Medicine, University of Turku, Kiinamyllynkatu 48, FIN-20520 Turku, Finland. E-mail:
tapani.ronnemaa{at}utu.fi
Obesity is associated with adverse changes in plasma lipoprotein
metabolism,but it is not known completely how this association is
modifiedby genetic factors. We assessed the contribution of obesityto
serum lipid and lipoprotein levels and lipid metabolizingenzyme
activities by examining 23 identical twin pairs (9 male,14 female) who
had, on the average, an 18-kg intrapair differencein BW. Compared with
lean co-twins, obese co-twins had approximately20% higher low-density
lipoprotein (LDL) cholesterol (P <0.01), 20%
lower high-density lipoprotein2 cholesterol
(P =0.010), and 90% (men) or 35% (women) higher
(P 0.06) total,very-low-density lipoprotein and
LDL triglycerides. The pairswere divided into subgroups by the
gender-specific median valueof abdominal visceral fat (AVF) area in
the obese co-twin andby apolipoprotein E 4 phenotype. The
intrapair differences inserum cholesterol fractions were similar in
twin pairs withhigh or low AVF, whereas only high AVF pairs showed
significantdifferences in triglyceride fractions. The greatest
intrapairdifferences in total, very-low-density lipoprotein and LDL
triglycerideswere observed in apolipoprotein E 4-positive pairs
expressinghigh AVF. Compared with lean co-twins, lecithin cholesterol
acyltransferaseactivity was 18% higher (P <
0.001) and hepatic lipase activitywas 38% higher
(P = 0.016) in obese co-twins with high AVF.When
genetic factors are identical, obesity is associated withan
atherogenic lipid profile, especially in subjects with highvisceral
fat accumulation.
This article has been cited by other articles:
C. Zhang, R. Lopez-Ridaura, E. B Rimm, N. Rifai, D. J Hunter, and F. B Hu Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men
Am. J. Clinical Nutrition,
June 1, 2005;
81(6):
1429 - 1435.
[Abstract][Full Text][PDF]
N. Yi, S. Chiu, D. B. Allison, J. S. Fisler, and C. H. Warden Epistatic interaction between two nonstructural loci on chromosomes 7 and 3 influences hepatic lipase activity in BSB mice
J. Lipid Res.,
November 1, 2004;
45(11):
2063 - 2070.
[Abstract][Full Text][PDF]
S. D. Sibley, J. P. Palmer, I. B. Hirsch, and J. D. Brunzell Visceral Obesity, Hepatic Lipase Activity, and Dyslipidemia in Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
July 1, 2003;
88(7):
3379 - 3384.
[Abstract][Full Text][PDF]
R. V. Andersen, H. H. Wittrup, A. Tybjaerg-Hansen, R. Steffensen, P. Schnohr, and B.o. G. Nordestgaard Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: The Copenhagen City Heart Study
J. Am. Coll. Cardiol.,
June 4, 2003;
41(11):
1972 - 1982.
[Abstract][Full Text][PDF]
D. R. Jones, R. J. Schmidt, R. T. Pickard, P. S. Foxworthy, and P. I. Eacho Estrogen receptor-mediated repression of human hepatic lipase gene transcription
J. Lipid Res.,
March 1, 2002;
43(3):
383 - 391.
[Abstract][Full Text][PDF]